Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Explore the credit cards that offer the best cash back rewards. Make your spending work for you.
28,278 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Lululemon is set to report its Q1 results tonight as margins, growth mix, and international exposure take center stag...
Midyear market shifts put Buffett's moat concept under stress as MOAT slips while the broad market climbs. Here’s wha...
Apple stock is trading in the high 300s as traders weigh a possible rally. Here are three catalysts that could push a...
Adobe has pulled back about 40% from its peak, but new AI-driven products and expanding ARR are reinvigorating the bu...
Goldman Sachs and KeyBanc boosted AT&T price targets after the telecom giant unveiled a three-segment reporting model...
As March unfolds, two names stand out in the evolving world of SMRs and clean power. This article breaks down why NuS...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
SpaceX grabs headlines, yet smart investors look for real performance. Meet two growth stocks I prefer over the hype:...
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
A volatile oil backdrop in mid-2026 is creating a rare entry point for Exxon Mobil. With disciplined costs and robust...
What the arcturus (arct) 2025 earnings report may reveal isn’t just about a single quarter. This guide breaks down th...